These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 6097311)
1. Lithium's effects on muscarinic receptor binding parameters: a relationship to therapeutic efficacy? Dilsaver SC Biol Psychiatry; 1984 Nov; 19(11):1551-65. PubMed ID: 6097311 [TBL] [Abstract][Full Text] [Related]
2. A cholinergic role in the mechanism of lithium in mania. Tollefson GD; Senogles S Biol Psychiatry; 1983 Apr; 18(4):467-79. PubMed ID: 6860721 [TBL] [Abstract][Full Text] [Related]
3. Effects of lithium on [3H](-)quinuclidinyl benzilate [( 3H](-)QNB) binding to rat brain muscarinic cholinergic receptors. Hruska RE; Ludmer LM; Pert A; Bunney WE J Neurosci Res; 1984; 11(2):171-7. PubMed ID: 6423831 [TBL] [Abstract][Full Text] [Related]
4. Reduced dark-adaptation: an indication of lithium's neuronal action in humans. Emrich HM; Zihl J; Raptis C; Wendl A Am J Psychiatry; 1990 May; 147(5):629-31. PubMed ID: 2327491 [TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms underlying mood stabilization in manic-depressive illness: the phenotype challenge. Ikonomov OC; Manji HK Am J Psychiatry; 1999 Oct; 156(10):1506-14. PubMed ID: 10518159 [TBL] [Abstract][Full Text] [Related]
6. Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in manic depressive illness. Manji HK; Moore GJ; Chen G J Clin Psychiatry; 2000; 61 Suppl 9():82-96. PubMed ID: 10826666 [TBL] [Abstract][Full Text] [Related]
7. Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications. Manji HK; Bebchuk JM; Moore GJ; Glitz D; Hasanat KA; Chen G J Clin Psychiatry; 1999; 60 Suppl 2():27-39; discussion 40-1, 113-6. PubMed ID: 10073385 [TBL] [Abstract][Full Text] [Related]
8. Neurobiology of lithium: an update. Lenox RH; McNamara RK; Papke RL; Manji HK J Clin Psychiatry; 1998; 59 Suppl 6():37-47. PubMed ID: 9674936 [TBL] [Abstract][Full Text] [Related]
9. In vivo imaging of the pharmacodynamics and pharmacokinetics of lithium. Kilts CD J Clin Psychiatry; 2000; 61 Suppl 9():41-6. PubMed ID: 10826660 [TBL] [Abstract][Full Text] [Related]
15. Electroconvulsive shock and neurotransmitter receptors: implications for mechanism of action and adverse effects of electroconvulsive therapy. Lerer B Biol Psychiatry; 1984 Mar; 19(3):361-83. PubMed ID: 6144329 [TBL] [Abstract][Full Text] [Related]
16. Down-regulation of PKC alpha by lithium in vitro. Bitran JA; Manji HK; Potter WZ; Gusovsky F Psychopharmacol Bull; 1995; 31(2):449-52. PubMed ID: 7491404 [TBL] [Abstract][Full Text] [Related]
17. [Calcium antagonists and lithium in preventive treatment of manic-depressive disorder]. Sarfati Y; Spadone C; Vanelle JM; Lôo H Encephale; 1996; 22(2):149-53. PubMed ID: 8706625 [TBL] [Abstract][Full Text] [Related]
18. Pharmacological perturbation of cholinergic systems: applications to the study of pathophysiological mechanisms in affective disorders. Dilsaver SC Hillside J Clin Psychiatry; 1988; 10(1):38-54. PubMed ID: 3044958 [TBL] [Abstract][Full Text] [Related]
19. The effect of atropine administered in the medial septum or hippocampus on high- and low-frequency theta rhythms in the hippocampus of urethane anesthetized rats. Li S; Topchiy I; Kocsis B Synapse; 2007 Jun; 61(6):412-9. PubMed ID: 17372965 [TBL] [Abstract][Full Text] [Related]
20. Signal transduction pathways. Molecular targets for lithium's actions. Manji HK; Potter WZ; Lenox RH Arch Gen Psychiatry; 1995 Jul; 52(7):531-43. PubMed ID: 7598629 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]